Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study

NCT02632903 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped While the clinical need for and the scientific merit remain valid, this regulated drug trial was not feasible logistically due to limited funds.

Conditions

Interventions

Sponsor

Children's Hospital of Eastern Ontario